More ImpediMed Limited news
ImpediMed LimitedASX: IPD

S&P DJI Announces March 2022 Quarterly Rebalance

Mar 4, 2022 at 6:22 AM EST · Issued by ImpediMed Limited

Filed with ASX · Mar 4, 2022 at 6:22 AM EST · 10 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2022-quarterly-rebalance-72

Watch ImpediMed's latest callImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29↗

ImpediMed Limited on 6ix

Story so far

  • S&P DJI Announces March 2019 Quarterly RebalanceMar 8, 2019

Earlier from ImpediMed

  • ImpediMed Announces End Stage Renal Disease Trial AgreementFeb 10, 2022
  • PREVENT Trial Peer-Reviewed and PublishedJan 31, 2022
  • Share Purchase Plan Successfully CompletedNov 17, 2021
  • AGM Presentation - November 2021Nov 9, 2021
  • 2021 Annual General Meeting - Chairmans AddressNov 9, 2021

Later from ImpediMed

  • AstraZeneca extends and increases Renal ContractMar 17, 2022
  • Appendix 4C & Quarterly Activities ReportApr 27, 2022
  • Lymphoedema Risk Factors Paper PublishedJul 10, 2022
  • ImpediMed CEO Announces DepartureJul 25, 2022
  • Appendix 4C & Quarterly Activities Report - Jun-2022 QtrJul 27, 2022
All ImpediMed news releases↗

Follow ImpediMed into a list and get an email when it puts out news.

Follow ImpediMed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer